Novel strategy to monitor apparent tumor-specific T cells in patients with cancer

Similar Items

• Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer
  od: van de Ven, Rieneke, i dr.
  Izdano: (2018)
• Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies
  od: Moudgil, Tarsem, i dr.
  Izdano: (2014)
• DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
  od: Hilton, Traci L, i dr.
  Izdano: (2013)
• Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
  od: Moudgil, Tarsem, i dr.
  Izdano: (2013)
• Comparison of proteomic and genomic analyses of vaccine cell lines shows men receiving prostate gvax immunotherapy develop increased humoral responses to common cell line proteins relative to mutated proteins
  od: Hulett, Tyler, i dr.
  Izdano: (2014)